Close to 40 million Covid-19 vaccine doses have already been distributed through the COVAX Facility, half of them in Africa, but vaccine supplies are still stalled due to "tremendous demand" especially in India, the World Health Organization (WHO) said.
COVAX, a WHO-led program to secure equitable access to vaccines for low and middle-income countries, "has, as of today, distributed just over 38.7 million doses and we expect to get past 40 million doses later this week," Bruce Aylward, the WHO's senior advisor to the director general on organisational change, said at a press conference on Monday, Xinhua news agency reported.
"Over 40 countries on the African continent will have received doses by the end of this week, and they will receive nearly half of the doses from COVAX," he added.
However, the COVAX Facility has experienced major difficulties in accessing vaccines, especially since the Serum Institute of India, "one of the main producers that supply the COVAX Facility" according to Aylward, cut back on AstraZeneca vaccine deliveries due to the "tremendous demand" created by the "escalating outbreak in India."
One solution suggested by the WHO to ensure proper immunization is to administer the second AstraZeneca dose after "12 weeks" or even a bit later, Aylward said.
At the same time, the WHO urged populations to continue practicing the infection control measures as vaccines represent just one approach to dealing with Covid-19.
"There was a nine per cent increase in transmissions last week, the seventh consecutive week when we've seen an increase in transmission, and a five percent increase in the number of deaths," said Maria Van Kerkhove, the WHO's technical lead on Covid-19.
"We are at a critical point of the pandemic right now," she stressed.
(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)
Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid-19, we continue to remain committed to keeping you informed and updated with credible news, authoritative views and incisive commentary on topical issues of relevance.
We, however, have a request.
As we battle the economic impact of the pandemic, we need your support even more, so that we can continue to offer you more quality content. Our subscription model has seen an encouraging response from many of you, who have subscribed to our online content. More subscription to our online content can only help us achieve the goals of offering you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practise the journalism to which we are committed.
Support quality journalism and subscribe to Business Standard.